ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
26th EORTC-NCI-AACR Symposium
18 - 21 Nov 2014
Centre de Convencions Internacional Barcelona (CCIB), Barcelona, Spain
Highlights of the EORTC-NCI-AACR Symposium
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Predicting the relapse of acute myeloid leukaemia with genetic screening
Dr Elaine Mardis - University of Washington, Washington, USA
Choosing personalised treatment options based on molecular evidence
Dr Funda Meric-Bernstam - MD Anderson Cancer Centre, Houston, USA
Frontiers of pharmacokinetics and metabolism in cancer research
Prof Godefridus Peters - VU University Medical Center, Amsterdam, Netherlands
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients
Prof Elizabeth Swisher - University of Washington, Washington, USA
Overcoming cancer resistance with enzyme inhibitors
Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
New drug, ASP8273, shows response in Japanese patients with treatment-resistant ...
Dr Haruyasu Murakami - Shizuoka Cancer Center, Shizuoka, Japan
The work and aims of SPECTA for better clinical trials
Dr Vassilis Golfinopoulos - European Organization for Research and Treatment of ...